Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
J.P.W. Van den Bergh is a professional consulting and research entity led by Professor Joost P.W. van den Bergh, a renowned internist-endocrinologist and expert in bone quality. The company provides specialized medical expertise, clinical research support, and strategic consulting services in the fields of osteoporosis and metabolic bone diseases. Based in the Netherlands and Belgium, the firm leverages Professor van den Bergh's extensive academic and clinical background at Maastricht UMC+ and VieCuri Medical Centre to advise pharmaceutical companies and healthcare organizations. Its core focus includes the application of advanced imaging techniques like HR-pQCT for bone strength assessment and the development of clinical guidelines for fracture prevention. Professor van den Bergh is a key opinion leader who has collaborated with major industry players such as Amgen, Eli Lilly, and UCB.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on J.P.W. Van den Bergh.